v3.26.1
Consolidated Statements Of Comprehensive Loss
¥ in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2025
CNY (¥)
¥ / shares
shares
Dec. 31, 2025
USD ($)
$ / shares
shares
Dec. 31, 2024
CNY (¥)
¥ / shares
shares
Dec. 31, 2023
CNY (¥)
¥ / shares
shares
Revenues:        
Revenues ¥ 539,568 $ 77,157 ¥ 515,822 ¥ 537,435
Cost of revenues:        
Cost of revenues: (136,654) (19,542) (153,422) (174,208)
Gross Profit 402,914 57,615 362,400 363,227
Operating expenses:        
Research and development expenses (166,494) (23,808) (232,290) (347,016)
Selling and marketing expenses (165,175) (23,620) (190,904) (247,711)
General and administrative expenses (126,090) (18,031) (261,638) (437,821)
Impairment loss on long-lived assets 0 0 (35,127) 0
Total operating expenses (457,759) (65,459) (719,959) (1,032,548)
Loss from operations (54,845) (7,844) (357,559) (669,321)
Interest income 8,053 1,152 12,212 17,956
Interest expenses (30) (4) 0 0
Other income (loss), net (257) (37) 4,706 484
Foreign exchange loss, net (6,711) (960) (100) (420)
Loss before income tax (53,790) (7,693) (340,741) (651,301)
Income tax expenses (1,556) (223) (5,885) (2,388)
Net loss (55,346) (7,916) (346,626) (653,689)
Net loss attributable to Burning Rock Biotech Limited (55,300) (7,916) (346,626) (653,689)
Other comprehensive income (loss), net of tax of nil:        
Foreign currency translation adjustments (4,089) (585) 3,485 4,189
Total comprehensive loss (59,435) (8,501) (343,141) (649,500)
Total comprehensive loss attributable to Burning Rock Biotech Limited ¥ (59,435) $ (8,501) ¥ (343,141) ¥ (649,500)
Common Class A [Member]        
Loss per share for class A and class B ordinary shares:        
Loss per share - basic | (per share) ¥ (0.52) $ (0.07) ¥ (3.37) ¥ (6.38)
Loss per share - diluted | (per share) ¥ (0.52) $ (0.07) ¥ (3.37) ¥ (6.38)
Weighted average shares outstanding used in loss per share computation:        
Weighted average shares outstanding used in loss per share - basic 88,979,617 88,979,617 85,610,197 85,071,691
Weighted-average number of ordinary shares outstanding – diluted 88,979,617 88,979,617 85,610,197 85,071,691
Common Class B [Member]        
Loss per share for class A and class B ordinary shares:        
Loss per share - basic | (per share) ¥ (0.52) $ (0.07) ¥ (3.37) ¥ (6.38)
Loss per share - diluted | (per share) ¥ (0.52) $ (0.07) ¥ (3.37) ¥ (6.38)
Weighted average shares outstanding used in loss per share computation:        
Weighted average shares outstanding used in loss per share - basic 17,324,848 17,324,848 17,324,848 17,324,848
Weighted-average number of ordinary shares outstanding – diluted 17,324,848 17,324,848 17,324,848 17,324,848
Service [Member]        
Revenues:        
Revenues ¥ 316,111 $ 45,203 ¥ 290,738 ¥ 345,030
Cost of revenues:        
Cost of revenues: (79,317) (11,342) (88,323) (101,638)
Product [Member]        
Revenues:        
Revenues 223,457 31,954 225,084 192,405
Cost of revenues:        
Cost of revenues: ¥ (57,337) $ (8,200) ¥ (65,099) ¥ (72,570)